Today, Stockchase Discover commented about whether LIN-N, CVS-N, DOL-T are stocks to buy or sell.
Bulls counter that revenue over that three-year time span has grown 7.8% and the PE of just under 10x is very attractive. Also, CVS’ 2.82% dividend yield is secure at a 70% payout ratio. As for Oak Tree, CVS needed to add primary care to keep pace with its competitors, so Oak Tree will pay off in time. Be patient. Add to the company’s fine debt management at roughly 40% debt to total capital. Read Buying pullbacks: DOL, UNH, Linde for our full analysis.
Linde consistently beats earnings. In early February, Linde reported their Q4 2022 EPS at $3.16 beating the expected $2.91. Increased prices and greater volumes meant higher revenues, specifically in the Americas which enjoyed a 12% YOY rise in operating profits. Linde also has a $9 billion backlog from clients who span everything from healthcare to making semiconductors and food supplies. One future use will be supplying Taiwan Semiconductor‘s new plant in Arizona; Linde will build a $600-million gas facility. Read: Buying pullbacks: DOL, UNH, Linde for our full analysis.
DOL’s chart shows an upward trend in the past 12 months from $66.66 to peak at $85.88, with higher highs and higher lows. Currently, DOL is trading right at its 50- and 200-day moving averages in the ballpark of $79-80. The current PE is 31x, so DOL is trading above its five-year median average of 28.95x and mathematical average of 28.39x. Shares are now toppy, so buy this on a pullback. DOL pays only a 0.28% dividend yield, but trades at a stable 0.75 beta. Yes, debt is significant, but so is cash flow. Read: Buying pullbacks: DOL, UNH, Linde for our full analysis.